Julia G. Butchko - Aug 3, 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Dev. & Tech. Officer
Signature: /s/ Pamela Yanchik Connealy, attorney-in-fact for Julia G. Butchko
Stock symbol: IMVT
Transactions as of: Aug 3, 2021
Transactions value $: $0
Form type: 4
Date filed: 8/4/2021, 04:10 PM
Next filing: Sep 14, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+285K	+479.51%	$0.00	345K	Aug 3, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units awards ("RSUs").
F2	50% of the RSUs will vest on January 1, 2022 and the remainder of the RSUs will vest on January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date.